To investigate whether Tet2ΔMye in aging hosts exacerbates liver fibrosis through the Ccl2/Ccl8–pMDMs–HSCs axis, we established a competitive bone marrow transplantation (BMT) model using Tet2-deficient BMCs (Fig. 9 A). This evidence concerns the gene CCL2 and Hepatic fibrosis.